Genetic Testing in Infantile Epilepsy: What Three Cases Show
⚠️ Infant dosing/safety: medication and diet decisions for infants require individualized medical guidance.
Source: Journal of family medicine and primary care
Summary
Researchers studied three cases of infantile epilepsy, which is a type of epilepsy that affects babies from birth to two years old. They focused on how genetics can help in diagnosing and managing this condition. The study highlights the importance of early diagnosis and treatment, as infantile epilepsy can lead to other health issues.
The case descriptions report genetic findings involving KCNQ2, PRRT2, and TBCK. Sequencing helped clarify different diagnoses in these three children. Two children were reported to become seizure-free after changes in their medicines, but there was no comparison group showing that genetic testing caused that improvement. Finding a genetic explanation is different from proving that testing improves treatment outcomes for all children.
This small case series illustrates how genetic information can help clinicians interpret a child’s condition and discuss prognosis and care. Three cases cannot estimate how often testing finds a cause, compare testing methods, or establish which medicines work best. Larger comparative studies are needed to evaluate effects on treatment and outcomes. Families can ask their specialist whether genetic evaluation would be useful in their child’s situation.
Source basis: Full-text journal article, including the three case descriptions; PubMed record and DOI 10.4103/jfmpc.jfmpc_953_25. Evidence type: Three-patient case series, without a comparison group. Source checked October 4, 2026.
Correction – October 4, 2026: Narrowed the title and distinguished diagnostic findings from demonstrated treatment benefit.
Suggest a correction: email hello@epilepsyexplained.com with the page URL, the passage in question, and a supporting source if available.
Free: Seizure First Aid Quick Guide (PDF)
Plus one plain-language weekly digest of new epilepsy research.
Unsubscribe anytime. No medical advice.